Showing 121-140 of 753 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Antipsychotics for delirium
Cochrane Systematic Reviews, 22-Oct-2008
Delirium occurs in up to 30% of hospitalised patients and is associated with prolonged hospital stay and increased morbidity and mortality. Recently published reports have suggested that the standard drug for delirium, haloperidol, a typical antipsychotic
- Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy
Cochrane Systematic Reviews, 19-Jan-2011
Highly active antiretroviral therapy has reduced the morbidity and mortality of patients with HIV/AIDS. A common first-line ART regimen in low-resource settings includes a non-nucleoside reverse transcriptase inhibitor (NNRTI) and two nucleoside reverse t
- Anti-spasticity agents for multiple sclerosis
Cochrane Systematic Reviews, 17-Sep-2008
Spasticity is a common problem in multiple sclerosis (MS) patients causing pain, spasms, loss of function and difficulties in nursing care. A variety of oral and parenteral medications are available.
- Antistreptococcal interventions for guttate and chronic plaque psoriasis
Cochrane Systematic Reviews, 12-Jan-2016
Guttate psoriasis is a distinctive acute form of psoriasis which characteristically occurs in children and young adults. It is closely associated with preceding streptococcal sore throat or tonsillitis. Some authorities have claimed that ordinary (chronic
- Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery
Cochrane Systematic Reviews, 21-Apr-2014
Peripheral arterial disease (PAD) is frequently treated by either an infrainguinal autologous (using the patient's own veins) or synthetic graft bypass. The rate of occlusion of the graft after one year is between 12% and 60%. To prevent occlusion, patien
- Antithrombotic drugs for carotid artery dissection
Cochrane Systematic Reviews, 6-Mar-2011
Extracranial internal carotid artery dissection (eICAD) is a leading cause of stroke in younger patients.
- Anti-tuberculous therapy for maintenance of remission in Crohn's disease
Cochrane Systematic Reviews, 11-Feb-2015
There have been a number of studies with conflicting results which have examined the effect of anti-tuberculous therapy in Crohn's disease. A meta-analysis was performed to evaluate the use of anti-tuberculous therapy for the maintenance of remission in C
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Cochrane Systematic Reviews, 10-Jan-2013
The risk of cytomegalovirus (CMV) infection in solid organ transplant recipients has resulted in the frequent use of prophylaxis with the aim of preventing the clinical syndrome associated with CMV infection. This is an update of a review first published
- Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis
Cochrane Systematic Reviews, 9-Jan-2015
Eye disease due to herpes simplex virus (HSV) commonly presents as epithelial keratitis which, though usually self-limiting, may persist or progress without treatment.
- Anxiolytics for smoking cessation
Cochrane Systematic Reviews, 21-Jun-2011
There are two reasons to believe anxiolytics might help in smoking cessation. Anxiety may be a symptom of nicotine withdrawal. Secondly, smoking could be due to an attempt to self-medicate an anxiety problem.
- Aripiprazole for schizophrenia
Cochrane Systematic Reviews, 28-Feb-2013
Treatment of people with schizophrenia using older typical antipsychotic drugs such as haloperidol can be problematic. Many fail to respond to these older antipsychotics and more people experience disabling adverse effects. Aripiprazole is said to be one
- Aripiprazole versus typical antipsychotic drugs for schizophrenia
Cochrane Systematic Reviews, 10-Nov-2009
Aripiprazole is a relatively new antipsychotic drug, said to be the prototype of a new third generation of antipsychotics; the so-called dopamine-serotonin system stabilisers. In this review we examine how the efficacy and tolerability of aripiprazole di
- Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
Cochrane Systematic Reviews, 5-Aug-2009
Endocrine therapy removes the influence of oestrogen on breast cancer cells and so hormonal treatments such as tamoxifen, megestrol acetate and medroxyprogesterone acetate have been in use for many years for advanced breast cancer. Aromatase inhibitors (A
- Artemether-lumefantrine for treating uncomplicated falciparum malaria
Cochrane Systematic Reviews, 9-Aug-2009
Artemether-lumefantrine is being recommended by the World Health Organization for treating uncomplicated malaria. It is expensive. We sought evidence of its superiority over existing treatment regimens.
- Aspirin for in vitro fertilisation
Cochrane Systematic Reviews, 29-Jun-2011
Aspirin is used to improve the outcome in women undergoing in vitro fertilisation despite inconsistent evidence of its efficacy. The most appropriate time to commence aspirin therapy and the length of treatment required are also still to be determined. Th
- Atypical antipsychotics for aggression and psychosis in Alzheimer's disease
Cochrane Systematic Reviews, 12-Apr-2012
Aggression, agitation or psychosis occur in the majority of people with dementia at some point in the illness. There have been a number of trials of atypical antipsychotics to treat these symptoms over the last five years, and a systematic review is neede
- Atypical antipsychotics for people with both schizophrenia and depression
Cochrane Systematic Reviews, 7-Dec-2011
Many people (up to 50%) with schizophrenia also have co-morbid depression. It has been suggested that new atypical antipsychotic drugs are beneficial for people with the two diagnoses.
- Azathioprine for multiple sclerosis
Cochrane Systematic Reviews, 10-Nov-2008
Azathioprine is the most widely used immunosuppressive treatment in multiple sclerosis (MS). It is an alternative to interferon beta for treating MS also because it is less expensive. Concerns about its safety, mainly a possible increased risk of malignan
- Azithromycin for acute lower respiratory tract infections
Cochrane Systematic Reviews, 2-Mar-2015
Acute lower respiratory tract infections (LRTI) range from acute bronchitis and acute exacerbations of chronic bronchitis to pneumonia. Approximately five million people die from acute respiratory tract infections annually. Among these, pneumonia represen
- Azoles for allergic bronchopulmonary aspergillosis associated with asthma
Cochrane Systematic Reviews, 4-Jun-2014
Allergic bronchopulmonary aspergillosis is hypersensitivity to the fungus Aspergillus fumigatus that complicates patients with asthma and cystic fibrosis. The mainstay of treatment for allergic bronchopulmonary aspergillosis remains oral corticosteroids,
